Jane Street’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.73K Buy
1,391
+1,039
+295% +$11.7K ﹤0.01% 11317
2025
Q4
$3.67K Sell
352
-154
-30% -$3.9K ﹤0.01% 10908
2025
Q3
$26.1K Buy
+506
New +$23.8K ﹤0.01% 10486
2024
Q4
Sell
-547
Closed -$103K 9986
2024
Q3
$103K Buy
547
+522
+2,088% +$113K ﹤0.01% 8981
2024
Q2
$6.14K Buy
+25
New +$6K ﹤0.01% 9149
2022
Q2
Sell
-13
Closed -$56K 10216
2022
Q1
$56K Buy
+13
New +$50.8K ﹤0.01% 9654
2021
Q3
Sell
-36
Closed -$208K 10315
2021
Q2
$208K Buy
+36
New +$207K ﹤0.01% 8761

Other funds holding ISPC

Jane Street's ISPC Position: Q1 2026 in Review

Jane Street increased its iSpecimen (ISPC) stake by 295% in Q1 2026, buying an estimated $11.7K and bringing the position to 1,391 shares worth $8.73K. The position accounts for ﹤0.01% of the portfolio, ranked #11317.

Jane Street first reported a position in ISPC in Q2 2021 and has held it in 7 quarters since. The position peaked at $208K in Q2 2021. 9 funds tracked by Wall St. Rank hold ISPC as of Q1 2026.

  • Jane Street held 1,391 shares of iSpecimen worth $8.73K as of Q1 2026.
  • Jane Street bought 1,039 iSpecimen shares in Q1 2026, an estimated $11.7K.
  • iSpecimen made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11317 holding.
  • Jane Street first reported a position in iSpecimen in Q2 2021 and has held it in 7 quarters since.
  • Jane Street's iSpecimen position peaked at $208K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.